Actively Recruiting
Acute Heart Failure - COngestion Discharge Evaluation
Led by Central Hospital, Nancy, France · Updated on 2023-06-05
110
Participants Needed
1
Research Sites
409 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Acute heart failure (AHF) is a major public health problem, associated with a 40% risk of death or re-hospitalisation at 3 months. This risk is significantly increased by insufficient decongestion at the end of hospitalisation for AHF assessed by a standardised clinical score, a natriuretic peptide dosage or by cardiac and pulmonary ultrasound . Adapting treatment according to lung congestion assessed by implantable devices (not reimbursed in France) improves the prognosis. However, due to the lack of a standardised congestion assessment, therapeutic adaptation in acute heart failure is currently empirical. The best multimodality approach to congestion evaluation is uncertain.
CONDITIONS
Official Title
Acute Heart Failure - COngestion Discharge Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized for acute heart failure
- Patients considered clinically ready for discharge after hospitalization for acute heart failure
- Age 18 years or older
- Patients who have received complete information about the study and signed the informed consent form
- Patients affiliated with or beneficiaries of a social security scheme
You will not qualify if you...
- Life expectancy of 3 months or less due to other serious illnesses
- Dialysis patients or those with kidney filtration rate below 15 ml/min/m2 at inclusion
- History of lung surgery such as lobectomy or pneumonectomy
- Severe lung or pleural diseases preventing reliable lung ultrasound images, including severe emphysema, chronic pleurisy, or pulmonary fibrosis
- Pregnant women, women who have recently given birth, or nursing mothers
- Adults under legal protection measures (guardianship, curatorship, or safeguard of justice)
- Adults unable to give consent
- Persons deprived of liberty by judicial or administrative decisions
- Persons receiving psychiatric care under relevant public health laws
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHRU de Nancy
Vandœuvre-lès-Nancy, France, 54500
Actively Recruiting
Research Team
N
Nicolas GIRERD, MD,PhD
CONTACT
S
Sanae BOUALI, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here